Novartis has been serving patients in Indonesia for more than 50 years, through our predecessor companies, Ciba and Sandoz.

Ianalumab prolonged the duration of safe platelet levels during and after treatment in patients with primary immune thrombocytopenia (ITP) previously treated with corticosteroids1,2 Patients treated ...

V Novartisu v Sloveniji enkrat letno razpisujemo štipendije za dijake in študente zaključnih letnikov različnih izobraževalnih področij, s poudarkom na smereh farmacija, kemija, kemijska tehnologija ...

Leader mondial dans le domaine de la santé, Novartis propose actuellement l’un des portefeuilles les plus complets du marché. Un portefeuille de médicaments innovants, développés par des personnes ...